arXiv:2608. 13797v1 Announce Type: new Abstract: Computational approaches to drug discovery involve multiple sub-problems, and among them, drug-target binding affinity prediction plays an important role.
By Jafin Khan, Md Hossain Shuvo
arXiv:2606. 02345v1 Announce Type: cross Abstract: Many machine learning problems, including similarity learning, ranking, and clustering, rely on empirical pairwise loss functions whose quadratic computational cost quickly becomes prohibitive at scale.
By Louise Davy, Stephan Cl\'emen\c{c}on, Charlotte Laclau
arXiv:2606. 11057v1 Announce Type: new Abstract: Despite its importance to applications in protein design, predicting protein properties like binding affinity and thermostability from sparse experimental data remains a significant challenge.
By Martin Jankowiak, Yerdos Ordabayev, Rudraksh Tuwani, Henry N. Ward, Hunter Nisonoff, James M. McFarland, Gevorg Grigoryan
arXiv:2607. 11701v1 Announce Type: cross Abstract: Quantitative Structure-Activity Relationship ($\mathtt{QSAR}$) modeling is a foundational computational methodology in early-stage drug discovery, heavily relied upon for predicting compound toxicity, bioavailability, and therapeutic potential.
By Mariano Caruso, Daniel Ruiz, Alejandro Giraldo, Guido Bellomo
arXiv:2608. 12219v1 Announce Type: new Abstract: Treating patients with combinations of drugs reduces the risk of resistance to any individual drug.
By Antoine de Mathelin, Christopher Tosh, Wesley Tansey
arXiv:2604. 24474v2 Announce Type: replace Abstract: Molecular similarity plays a central role in ligand-based drug discovery, such as virtual screening, analog searching, and goal-directed molecular generation.
By Shiyun Wa, Yifei Wang, Simone Sciabola, Ye Wang
Learning neural set functions is pivotal to a wide range of important applications, including compound selection in AI-driven drug discovery and product recommendation. Recent work has introduced optimal subset oracles to implicitly learn set functions under practical weakly supervised settings, where model parameters are optimized through mean-field variational inference.
arXiv:2607. 11555v1 Announce Type: new Abstract: Learning neural set functions is pivotal to a wide range of important applications, including compound selection in AI-driven drug discovery and product recommendation.
By Yongquan Shi, Zijing Ou, Shiping Wang, Yatao Bian
arXiv:2606. 26657v1 Announce Type: new Abstract: Identifying high-utility candidates from massive discrete spaces under expensive evaluations is a recurring challenge across the sciences, with structure-based drug discovery as a prominent example.
By Mohammad Haddadnia, Yuvan Chali, Abhilash Jayaraj, Constance Kraay, Joana Reis, Felix Strieth-Kalthoff, Haribabu Arthanari
arXiv:2506. 13196v5 Announce Type: replace Abstract: Accurate prediction of protein-ligand binding affinity is critical for drug discovery.
By Han Liu, Keyan Ding, Peilin Chen, Yinwei Wei, Liqiang Nie, Dapeng Wu, Shiqi Wang
arXiv:2412. 05894v2 Announce Type: replace-cross Abstract: Federated learning (FL) enables collaborative analysis of biomedical data without exchanging sensitive patient-level information, but its performance in multi-center studies may be compromised by batch effects which can obscure biological signals.
By Yuliya Burankova, Julian Klemm, Jens J. G. Lohmann, Anne Hartebrodt, Ahmad Taheri, Niklas Probul, Jan Baumbach, Olga Zolotareva
arXiv:2509. 00704v2 Announce Type: replace Abstract: The scalability of pool-based active learning is limited by the computational cost of evaluating large unlabeled datasets, a challenge that is particularly acute in virtual screening for drug discovery.
By Renfei Zhang, Mohit Pandey, Artem Cherkasov, Martin Ester